Boundless Bio, Inc. Share Price
NASDAQ: BOLD | Micro CapBoundless Bio, Inc. Stock Performance
Open $2.81 | Prev. Close $2.88 | Circuit Range N/A |
Day Range $2.81 - $2.85 | Year Range $0.98 - $3.12 | Volume 2,053 |
Average Traded $2.83 |
Boundless Bio, Inc. Share Price Today
As of 29 August 2026, Boundless Bio, Inc.'s share price is $2.84. The stock opened at $2.81, compared to its previous close of $2.88. During today's trading session, Boundless Bio, Inc.'s share price traded between $2.81 and $2.85, with an average price of $2.83. Over the past 52 weeks, the stock has recorded a high of $3.12 and a low of $0.98. In terms of performance, Boundless Bio, Inc.'s share price has risen by 144.83% over the last six months and is up 153.57% on a year-on-year basis.
Boundless Bio, Inc. Share Price Chart
Boundless Bio, Inc. Stock Fundamentals & Key Indicators
Market Cap $63.50M | PE Ratio (TTM) -1.09 | Dividend Yield N/A |
EPS (TTM) $-2.60 | Revenue (TTM) N/A | Return On Equity (TTM) -58.99% |
Profit Margin N/A | Debt to Equity 0.13 | Quarterly Earnings Growth YoY 15.93% |
Boundless Bio, Inc. Quarterly Profit & Loss
All figures in USD
Boundless Bio, Inc. Annual Profit & Loss
All figures in USD
About Boundless Bio, Inc.
Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company's lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 demonstrating central nervous system penetrance in preclinical models. In addition, the company offers ECHO, an ecDNA harboring oncogenes diagnostic test to detect ecDNA in patient tumor specimens; and Spyglass platform, a platform used to identify druggable targets in oncogene amplified cancers. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Boundless Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.51 | $2.88 | +15.66% |
Jul 2026 | $2.50 | $2.49 | -0.60% |
Jun 2026 | $1.46 | $2.50 | +71.58% |
May 2026 | $1.51 | $1.46 | +0.34% |
Apr 2026 | $1.14 | $1.46 | +31.08% |
Mar 2026 | $1.13 | $1.11 | -4.31% |
Feb 2026 | $1.14 | $1.16 | +0.87% |
Jan 2026 | $1.22 | $1.15 | -3.36% |
Dec 2025 | $1.17 | $1.19 | +3.03% |
Nov 2025 | $1.28 | $1.16 | -15.69% |
Oct 2025 | $1.23 | $1.37 | +11.84% |
Sep 2025 | $1.11 | $1.23 | +9.37% |
BOLD Share Price FAQs
What is Boundless Bio, Inc. share price today?
What is the 52 week high and 52 week low of Boundless Bio, Inc. stock?
What is BOLD's market capitalisation today?
What is BOLD's net income for the last quarter?
What is the 5 year returns of BOLD?
What is the high & low stock price of BOLD today?
Can I buy BOLD shares in India?